Literature DB >> 14622506

[Evaluation through the EORTC questionnaires of long-term quality of life in patients with breast cancer in initial stages].

J I Arraras Urdaniz1, J J Illarramendi Mañas, A Manterola Burgaleta, M Tejedor Gutiérrez, R Vera García, J J Valerdi Alvarez, M A Domínguez Domínguez.   

Abstract

BASIS: The objective of the present work is to evaluate the quality of life of a group of patients with breast cancer after a long follow-up time.
METHODS: 104 patients with breast cancer in initial stages, of a total of 125 to whom the questionnaire was sent, have completed the general questionnaire QLQ-C30 and the module of the breast QLQ-BR23 of the EORTC in 2001, five years after their diagnosis. A subgroup of 48 patients had completed these questionnaires in 1996. The scorings of quality of life and the differences among the measurements of 2001 and 1996 have been evaluated, and groups organized according to the stage, the type of treatment, and the surgery have been compared.
RESULTS: The scorings of quality of life are appropriate and similar in both periods (1996 and 2001). There are alterations in the sexual function and concern over the future. The differences between the type of surgery focus on the corporal image. There are not significant differences in the analyses according to the stage or according to the type of treatment.
CONCLUSIONS: The scorings of quality of life indicate that the situation of these patients is satisfactory. The differences in the type of surgery are similar to the ones observed in the literature.

Entities:  

Mesh:

Year:  2003        PMID: 14622506     DOI: 10.1157/13053726

Source DB:  PubMed          Journal:  Rev Clin Esp        ISSN: 0014-2565            Impact factor:   1.556


  1 in total

Review 1.  Heath-related quality of life in Spanish breast cancer patients: a systematic review.

Authors:  María Concepción Delgado-Sanz; María José García-Mendizábal; Marina Pollán; Maria João Forjaz; Gonzalo López-Abente; Nuria Aragonés; Beatriz Pérez-Gómez
Journal:  Health Qual Life Outcomes       Date:  2011-01-14       Impact factor: 3.186

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.